Latest solution identifies, highlights & categorizes key positive findings to support clinicians, taking total FDA cleared indications to 26NEW YORK--(BUSINESS WIRE)--The US Food and Drug ...

The full MIST2 dosing regimen for IET was protective against treatment escalation and bleeding in patients with parapneumonic effusion and empyema. The intrapleural enzyme therapy (IET) dosing regimen ...

Researchers at the Technical University of Munich (TUM) have developed a medical robotic system to relieve a life-threatening tension pneumothorax in the chest cavity. The researchers are presenting ...

Background Tuberculous pleurisy (TBP) is a leading aetiology of exudative pleural effusion in tuberculosis (TB)-endemic regions and poses significant diagnostic challenges due to its paucibacillary ...

Department of Orthopaedic Surgery, Kanuni Sultan Suleyman Training and Research Hospital, Istanbul, Türkiye. Background: Osteosarcoma is the most common primary malignant bone tumor in children and ...

Pleural Dynamics today announced positive results from a prospective, multicenter study evaluating its ACES (automatic continuous effusion shunt) device. Plymouth, Minnesota-based Pleural Dynamics ...

Pleural Dynamics announced today that it received a new CMS code for its ACES (automatic continuous effusion shunt) device. CMS issued a new Healthcare Common Procedure Coding System (HCPCS) code and ...

Pleural Dynamics’ innovative, fully implantable, patient motion powered shunt offers patients a low maintenance option for continuous relief from pleural effusions MINNEAPOLIS--(BUSINESS ...

Chest X-ray classification model for detecting pleural effusion using transfer learning. The project utilizes ResNet50V2 and data augmentation to improve classification accuracy.

The global chest drainage system market is expected to grow from USD 1.09 billion in 2025 to USD 1.95 billion by 2035, expanding at a CAGR of 6% during the forecast period. Pleural drainage systems ...

LODESTAR: A single-arm phase II study of rucaparib in solid tumors with pathogenic germline or somatic variants in homologous recombination repair genes. The efficacy and safety of a selective PARP1 ...